nimodipine and Coma
nimodipine has been researched along with Coma in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors report on the use of nimodipine in 36 patients for coma due to severe cerebral (20 haemorrhagic, 2 ischaemic, 9 post-anoxic, 4 traumatic, 1 neoplastic) lesions." | 7.68 | [The use of nimodipine in comatose patients with different types of cerebrovascular pathology]. ( Alia, G; Mattaliano, A, 1993) |
| "We report a 39-year-old male with an aneurysmal subarachnoid hemorrhage without hydrocephalus, in whom a right choroidal aneurysm was early excluded by endovascular coil insertion." | 5.51 | [Continuous intra arterial nimodipine for vasospasm secondary to subarachnoid hemorrhage. Report of one case]. ( Contreras, L; Cordovez, J; Ducci, H; Galvez, M; Mena, F; Reccius, A; Regueira, T; Soto, L; Torres, F, 2019) |
| "The authors report on the use of nimodipine in 36 patients for coma due to severe cerebral (20 haemorrhagic, 2 ischaemic, 9 post-anoxic, 4 traumatic, 1 neoplastic) lesions." | 3.68 | [The use of nimodipine in comatose patients with different types of cerebrovascular pathology]. ( Alia, G; Mattaliano, A, 1993) |
| "We report a 39-year-old male with an aneurysmal subarachnoid hemorrhage without hydrocephalus, in whom a right choroidal aneurysm was early excluded by endovascular coil insertion." | 1.51 | [Continuous intra arterial nimodipine for vasospasm secondary to subarachnoid hemorrhage. Report of one case]. ( Contreras, L; Cordovez, J; Ducci, H; Galvez, M; Mena, F; Reccius, A; Regueira, T; Soto, L; Torres, F, 2019) |
| "To determine if the age of packed red blood cells (PRBCs) is associated with adverse events or outcomes in patients with subarachnoid haemorrhage (SAH)." | 1.37 | Packed red blood cell age does not impact adverse events or outcomes after subarachnoid haemorrhage. ( Ault, ML; Duran, IM; Liebling, SM; Naidech, AM, 2011) |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Regueira, T | 1 |
| Reccius, A | 1 |
| Ducci, H | 1 |
| Torres, F | 1 |
| Soto, L | 1 |
| Cordovez, J | 1 |
| Galvez, M | 1 |
| Contreras, L | 1 |
| Mena, F | 1 |
| Naidech, AM | 1 |
| Liebling, SM | 1 |
| Duran, IM | 1 |
| Ault, ML | 1 |
| Alia, G | 1 |
| Mattaliano, A | 1 |
Other Studies
3 other studies available for nimodipine and Coma
| Article | Year |
|---|---|
[Continuous intra arterial nimodipine for vasospasm secondary to subarachnoid hemorrhage. Report of one case].
Topics: Adult; Angiography; Coma; Computed Tomography Angiography; Humans; Male; Nimodipine; Subarachnoid He | 2019 |
Packed red blood cell age does not impact adverse events or outcomes after subarachnoid haemorrhage.
Topics: Adult; Aged; Blood Preservation; Cerebral Infarction; Coma; Erythrocyte Aging; Erythrocyte Transfusi | 2011 |
[The use of nimodipine in comatose patients with different types of cerebrovascular pathology].
Topics: Acute Disease; Adolescent; Adult; Aged; Cerebrovascular Disorders; Child; Coma; Drug Evaluation; Fem | 1993 |